Randomized Controlled Trial of Intergrated Early Palliative Care
- Conditions
- Neoplasms
- Registration Number
- KCT0003353
- Lead Sponsor
- Seoul National University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 144
•Subject 20 years and older.
•Subject who has an advanced cancer diagnosis (histologically or cytologically confirmed) due to a solid tumor
•Subject whose ECOG performance status is between 0 to 2.
•Subject with an estimated life expectancy of 12 months and less (assessed by the treating oncologist)
•Subject who volunteers
•Inability to speak, understand or write Korean.
•Medical conditions that would limit adherence to participation of the clinical trial(as confirmed by their referring physician; e.g. dyspnea)
•Suspension of all cancer treatment
•Palliative care consultation at any time or in palliative care
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in level of EORTC QLQ-C15-PA
- Secondary Outcome Measures
Name Time Method Change in level of MQOL;Change in level of EQ-5D of EuroQoL;Change in level of PHQ-9;Change in level of Understanding the illness;Change in level of Crisis Overcoming Capability(SAT-SF);Change in Advance Care Preference;Medical cost and utilization of complementary and alternative medicine;1 year survival;Changes of CQOL;Change in level of PHQ-9 of family caregivers;Understanding the illness of family caregivers;Change in level of Crisis Overcoming Capability(SAT-SF) of family caregivers;Change in Advance Care Preference of family caregivers;Change in Quality Care Questionnaire of family caregivers